Company:  ATARA BIOTHERAPEUTICS, IN ... (ATRA)
Form Type:  424B5
Filing Date:  2/27/2020 
CIK:  0001604464 
Address:  611 GATEWAY BLVD
SUITE 900
 
City, State, Zip:  SOUTH SAN FRANCISCO, California 94080 
Telephone:  650-278-8930 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$9.74  
Change: 
0.075 (0.78%)  
Trade Time: 
Jun 05  
Market Cap: 
$697.24M
Trade ATRA now with 

© 2020  
Description of Business
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company that is developing novel treatments for patients with cancer, autoimmune and viral diseases. We have several T-cell immunotherapies in clinical development and are progressing a next-generation allogeneic chimeric antigen receptor T-cell, or CAR T program.
Register and access this filing in:     
  FORM 424B5
    CALCULATION OF REGISTRATION FEE
    TABLE OF CONTENTS
      INCOME STATEMENT
    ABOUT THIS PROSPECTUS SUPPLEMENT
      Employees
    THE OFFERING
    RISK FACTORS
    SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS
    USE OF PROCEEDS
    DILUTION
    DESCRIPTION OF CAPITAL STOCK
    Transfer Agent and Registrar
    PLAN OF DISTRIBUTION
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
      INCOME STATEMENT
    Description of Securities
    Use of Proceeds
    RISK FACTORS
    USE OF PROCEEDS
    RATIO OF EARNINGS TO FIXED CHARGES
    DESCRIPTION OF CAPITAL STOCK
    DESCRIPTION OF DEBT SECURITIES
    DESCRIPTION OF WARRANTS